Schroder Group Acquires 5% Stake in Apollo Hospitals via Open Market
Team Finance Saathi
28/Nov/2024

What's covered under the Article:
- Schroder Investment Management increases its stake in Apollo Hospitals to 5.01%.
- Acquisition made via open market, per SEBI Regulation 29 disclosure requirements.
- The move strengthens foreign interest in India's healthcare sector.
Schroder Investment Management (Singapore) Ltd, part of the Schroder Group, has officially become a substantial shareholder in Apollo Hospitals Enterprise Ltd. As per regulatory filings made on 27 November 2024, the acquisition took place through an open market transaction, marking a significant development in the healthcare sector.
Shareholding Details
The transaction occurred on 25 November 2024, increasing Schroder Group's total shareholding in Apollo Hospitals to 7,203,348 shares, equivalent to 5.01% of the total voting capital. Prior to this acquisition, Schroder held 4.979% (7,157,069 shares) of Apollo Hospitals. With an additional 46,279 shares acquired, the group has crossed the 5% threshold, necessitating disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Foreign Investment in Healthcare
This acquisition underscores the growing foreign interest in India's healthcare sector, particularly in high-performing companies like Apollo Hospitals. Schroder Group's increased stake signals confidence in Apollo's operational excellence and growth potential.
The Upcoming IPOs in this week and coming weeks are Agarwal Toughened, Ganesh Infraworld, Suraksha Diagnostic, Property Share REIT, Rosmerta Digital, Avanse Financial and Nisus Finance.
The Current active IPO is Apex Ecotech, Abha Power and Steel, Rajputana Biodiesel, and Rajesh Power Services.
Apollo Hospitals, listed on both the National Stock Exchange of India (NSE) and The Bombay Stock Exchange (BSE), remains one of the most sought-after stocks in India's healthcare space.
Mode of Acquisition
The acquisition was executed via the open market, highlighting Schroder's strategy of gradual accumulation rather than large block purchases. This method also ensures minimal disruption in the share price while allowing investors to strengthen their holdings strategically.
Compliance and Regulatory Aspects
As part of regulatory compliance, Schroder Group submitted the requisite forms to SEBI, detailing the specifics of the acquisition. Notable highlights include:
- Date of transaction: 25 November 2024
- Mode of acquisition: Open market
- Shareholding post-acquisition: 5.01%
- Voting rights: Unchanged as per total diluted capital
This disclosure demonstrates transparency and adherence to SEBI's regulations, ensuring confidence among stakeholders and regulatory authorities.
Impact on Apollo Hospitals
Apollo Hospitals continues to be a leader in India's healthcare industry. This acquisition by a reputed global investment management group further enhances the company’s credibility and showcases its attractiveness as a high-value investment destination.
The healthcare sector in India has witnessed a surge in foreign investments due to its expansion potential, driven by increasing demand for quality healthcare services and robust infrastructure. Apollo's ability to consistently deliver superior healthcare solutions makes it a prime choice for institutional investors like Schroder Group.
For more updates on stock acquisitions, healthcare sector investments, and regulatory filings, explore Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance Saathi and Top News Headlines - Share Market News, Latest IPO News, Business News, Economy News - Finance Saathi.
Join our Trading with CA Abhay Telegram Channel for expert trading calls and Finance Saathi Telegram Channel for regular market updates and news.
Start your investment journey today with a Free Demat Account in Choice Broking FinX and take your portfolio to new heights!
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.